153 related articles for article (PubMed ID: 19783782)
1. Angiotensin II effects on ischemic focal ventricular tachycardia are predominantly mediated through myocardial AT(2) receptor.
Gopinathannair R; Chaudhary AK; Xing D; Ely D; Zheng W; Martins JB
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1889-98. PubMed ID: 19783782
[TBL] [Abstract][Full Text] [Related]
2. Triggered activity due to delayed afterdepolarizations in sites of focal origin of ischemic ventricular tachycardia.
Xing D; Martins JB
Am J Physiol Heart Circ Physiol; 2004 Nov; 287(5):H2078-84. PubMed ID: 15475531
[TBL] [Abstract][Full Text] [Related]
3. Prevention of ischemic ventricular tachycardia of Purkinje origin: role for alpha(2)-adrenoceptors in Purkinje?
Arnar DO; Xing D; Lee H; Martins JB
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1182-90. PubMed ID: 11179062
[TBL] [Abstract][Full Text] [Related]
4. Free radical scavenger specifically prevents ischemic focal ventricular tachycardia.
Xing D; Chaudhary AK; Miller FJ; Martins JB
Heart Rhythm; 2009 Apr; 6(4):530-6. PubMed ID: 19324315
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin specifically prevents focal ischemic ventricular tachycardia due to triggered activity.
Xing D; Murry DJ; Schmidt MS; Hohl RJ; Martins JB
Heart Rhythm; 2007 May; 4(5):629-37. PubMed ID: 17467633
[TBL] [Abstract][Full Text] [Related]
6. Role of the Purkinje system in spontaneous ventricular tachycardia during acute ischemia in a canine model.
Arnar DO; Bullinga JR; Martins JB
Circulation; 1997 Oct; 96(7):2421-9. PubMed ID: 9337219
[TBL] [Abstract][Full Text] [Related]
7. Role of NADPH oxidase and xanthine oxidase in mediating inducible VT/VF and triggered activity in a canine model of myocardial ischemia.
Martins JB; Chaudhary AK; Jiang S; Kwofie M; Mackie P; Miller FJ
Int J Mol Sci; 2014 Nov; 15(11):20079-100. PubMed ID: 25375191
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-induced sudden arrhythmic death and electrical remodeling.
Fischer R; Dechend R; Gapelyuk A; Shagdarsuren E; Gruner K; Gruner A; Gratze P; Qadri F; Wellner M; Fiebeler A; Dietz R; Luft FC; Muller DN; Schirdewan A
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1242-53. PubMed ID: 17416596
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological stimulation of cardiac gap junction coupling does not affect ischemia-induced focal ventricular tachycardia or triggered activity in dogs.
Xing D; Kjølbye AL; Petersen JS; Martins JB
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H511-6. PubMed ID: 15650154
[TBL] [Abstract][Full Text] [Related]
10. Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy.
Pogwizd SM
Circulation; 1994 Sep; 90(3):1441-58. PubMed ID: 7522134
[TBL] [Abstract][Full Text] [Related]
11. Effects of lidocaine and diltiazem on recovery of electrophysiologic activity during partial reperfusion following severe myocardial ischemia in canine hearts.
Murasato Y; Nagamoto Y; Urabe T; Kuraoka F; Nakashima Y; Kuroiwa A
J Electrocardiol; 1997 Apr; 30(2):113-25. PubMed ID: 9141606
[TBL] [Abstract][Full Text] [Related]
12. Alpha-2 adrenergic antagonism enhances risk of ventricular tachycardia during acute ischemia.
Arnar DO; Xing D; Martins JB
Scand Cardiovasc J; 2007 Dec; 41(6):378-85. PubMed ID: 17852790
[TBL] [Abstract][Full Text] [Related]
13. Focal initiation of sustained and nonsustained ventricular tachycardia in a canine model of ischemic cardiomyopathy.
Johnson CM; Pogwizd SM
J Cardiovasc Electrophysiol; 2012 May; 23(5):543-52. PubMed ID: 22175759
[TBL] [Abstract][Full Text] [Related]
14. Purkinje involvement in arrhythmias after coronary artery reperfusion.
Arnar DO; Martins JB
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1189-96. PubMed ID: 11893551
[TBL] [Abstract][Full Text] [Related]
15. ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs.
Xing D; Kjølbye AL; Nielsen MS; Petersen JS; Harlow KW; Holstein-Rathlou NH; Martins JB
J Cardiovasc Electrophysiol; 2003 May; 14(5):510-20. PubMed ID: 12776869
[TBL] [Abstract][Full Text] [Related]
16. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanism of postinfarction ventricular tachycardia originating in surviving left posterior Purkinje fibers.
Hayashi M; Kobayashi Y; Iwasaki YK; Morita N; Miyauchi Y; Kato T; Takano T
Heart Rhythm; 2006 Aug; 3(8):908-18. PubMed ID: 16876739
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion.
Dhalla AK; Wang WQ; Dow J; Shryock JC; Belardinelli L; Bhandari A; Kloner RA
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1923-9. PubMed ID: 19767532
[TBL] [Abstract][Full Text] [Related]
19. Ventricular tachycardia originating from the posterior papillary muscle in the left ventricle: a distinct clinical syndrome.
Doppalapudi H; Yamada T; McElderry HT; Plumb VJ; Epstein AE; Kay GN
Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):23-9. PubMed ID: 19808390
[TBL] [Abstract][Full Text] [Related]
20. Overdrive pacing of early ischemic ventricular tachycardia: evidence for both reentry and triggered activity.
Arnar DO; Xing D; Martins JB
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1124-30. PubMed ID: 15706044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
